Nuo Therapeutics, Inc. (AURX)
OTCMKTS · Delayed Price · Currency is USD
1.000
+0.230 (29.87%)
Aug 17, 2026, 11:22 AM EST

Nuo Therapeutics Statistics

Total Valuation

AURX has a market cap or net worth of 48.41 million. The enterprise value is 49.77 million.

Market Cap48.41M
Enterprise Value 49.77M

Important Dates

The next estimated earnings date is Thursday, August 20, 2026.

Earnings Date Aug 20, 2026
Ex-Dividend Date n/a

Share Statistics

AURX has 48.41 million shares outstanding. The number of shares has increased by 3.15% in one year.

Current Share Class 48.41M
Shares Outstanding 48.41M
Shares Change (YoY) +3.15%
Shares Change (QoQ) +0.25%
Owned by Insiders (%) 47.99%
Owned by Institutions (%) 0.01%
Float 20.28M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 9.31
PB Ratio -31.53
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 9.57
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.28

Current Ratio 1.28
Quick Ratio 1.04
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -0.74
Interest Coverage -5.98

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -54.33%
Return on Invested Capital (ROIC) -210.16%
Return on Capital Employed (ROCE) -161.57%
Weighted Average Cost of Capital (WACC) -4,127.55%
Revenue Per Employee 520,003
Profits Per Employee -201,247
Employee Count10
Asset Turnover 2.61
Inventory Turnover 8.58

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -42.53% in the last 52 weeks. The beta is -779.39, so AURX's price volatility has been lower than the market average.

Beta (5Y) -779.39
52-Week Price Change -42.53%
50-Day Moving Average 1.05
200-Day Moving Average 1.65
Relative Strength Index (RSI) 51.19
Average Volume (20 Days) 3,400

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, AURX had revenue of 5.20 million and -2.01 million in losses. Loss per share was -0.04.

Revenue5.20M
Gross Profit 3.33M
Operating Income -1.73M
Pretax Income -2.01M
Net Income -2.01M
EBITDA -1.64M
EBIT -1.73M
Loss Per Share -0.04
Full Income Statement

Balance Sheet

The company has 449,325 in cash and 1.81 million in debt, with a net cash position of -1.36 million or -0.03 per share.

Cash & Cash Equivalents 449,325
Total Debt 1.81M
Net Cash -1.36M
Net Cash Per Share -0.03
Equity (Book Value) -1.54M
Book Value Per Share -0.03
Working Capital 439,434
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.15 million and capital expenditures -297,079, giving a free cash flow of -2.45 million.

Operating Cash Flow -2.15M
Capital Expenditures -297,079
Depreciation & Amortization 95,514
Net Borrowing 1.68M
Free Cash Flow -2.45M
FCF Per Share -0.05
Full Cash Flow Statement

Margins

Gross margin is 64.11%, with operating and profit margins of -33.32% and -38.70%.

Gross Margin 64.11%
Operating Margin -33.32%
Pretax Margin -38.70%
Profit Margin -38.70%
EBITDA Margin -31.48%
EBIT Margin -33.32%
FCF Margin n/a

Dividends & Yields

AURX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.15%
Shareholder Yield -3.15%
Earnings Yield -4.16%
FCF Yield -5.05%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2